INTRODUCTION
Dipeptidyl peptidase-4 (DPP-4) is an enzyme produced by various tissues in the body that works to deactivate the hormone increatin, namely GLP-1 and GIP when carrying out its functions in blood sugar homeostasis. 1 By inhibiting DPP-4 activity an effect will be obtained suppression of increased blood glucose so that the development of DPP-4 inhibiting agents is being carried out throughout the world as a therapy for diabetes mellitus. 2 Currently several anti-diabetic synthetic drugs with the DPP-4 inhibitor working mechanism have been marketed, such as sitagliptin, vidagliptin, saxagliptin, linagliptin and alogliptin. 3 Although DPP-4 inhibiting agents have advantages such as not causing hypoglycemia and weight loss, and can be used as monotherapy or in combination with other anti-diabetic agents, these synthetic drugs have several side effects such as headache, diarrhea, joint pain, sore throat, nasal congestion and serious side effects, namely heart failure. [3] [4] [5] So it is necessary to develop other sources that have DPP-4 inhibiting activities that are safer such as from natural ingredients.
Morus alba is biogeographically included in the family Moraceae and genus Morus that live in various countries including Indonesia. 6 This plant is still used in traditional medicine to protect liver damage, strengthen joints, expedite urine expenditure, lower blood pressure, and reduce blood sugar levels. 7 Research on leaves, root bark, and fruit Morus alba (MA) proves the existence of anti-diabetic effects. 2 However, there has been no study of MA stem bark as an anti-diabetic specifically as a dedication to DPP-4 activity.
The genus Morus has several species and phylogenetic relationships between them. Many studies have attempted to classify Morus species, resulting in varied numbers of designated Morus spp. The information from internal transcribed spacer (ITS) genetic sequences to the study of the members of the general accepted the genus Morus.
The classification of the ITS sequences of known interspecific hybrid clones into both the maternal and the maternal indicated that it was sufficient to distinguish interspecific hybrids in the genus Morus. Nanang Sasmita, et MA stem bark is known to contain apigenin, luteolin, quercetin, morine, caffeic acid, gallic acid, routine, umbelliferone, chlorogenic acid, and kaempferol. 8 Apigenin is a compound of more than 20 compounds found in plants reported to have DPP-4 inhibitory activity. 9 In a study by Junfeng Fan et al (2013) proving that apigenin compounds have potent DPP-4 inhibitory activity with IC50 0.14 ± 0.02 M. 2 Flavonoids in plants can be found in the form of glycosides in several glycosidic combinations. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] Apigenin is one of the flavonoid compounds from plant secondary metabolites that are often found in the form of glycosides. 28 The hydrolysis method is used to release aglycones in the extract so that it can be further identified by HPLC.
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MATERIALS AND METHODS
Samples
Stem bark of MA purchased from the local farmer on Sukabumi, West Java and determination by Lembaga Ilmu Pengetahuan Indonesia (LIPI).
Chemical
The standard of Apigenin was purchased from China (Shanghai Yuanye Bio-Technology Co.Ltd), Ethanol (Merck, Germany), DPP-4 Assay Kit (Cayman chemical, USA), Acetonitrile and methanol with analytical grade for HPLC was purchased from a local distributor.
Extraction process
The dried stem bark of MA was cleaned and ground to a powder using a plant disintegrator. Ethanolic extract : 10 gr sample powder was macerated with 100 ml distilled ethanol 96% on round bottom flask (Duran, Germany) for 1 hour and then extraction by microwave assisted extraction (Modena MV-3002, with slight modification) with power 70 watt for 5 minutes. 5 The extract were evaporated with a rotary vacuum evaporator (Rotavapor R-215, Buchi, Switzerland) until obtained concentrated extract. The remaining solvent was removed using a vacuum oven at 37° C for 24 hours. 10 Ethanolic extract with hydrolyzed acid: 30 mg dry ethanol extract added 3 ml of HCl 2 N then heated on boiling water for 10 minutes, then mixed with 3 ml of ethyl acetate, centrifuged for 20 minutes at 3,000 rpm. Ethyl acetate fraction was taken. The solvent residue was completely removed by drying at room temperature for 48 hours. The obtained extracts were stored in a refrigerator at -20 0 C until the analyzed.
Thin layer chromatography (TLC)
TLC used silica gel analytical plates test, 60 F 254 (Merck, Germany) as a stationary phase. Plate adjusted to size 4 x 6 cm. Sample solution and standard solution (1000 μl/ml for both solutions) were spotted on the plate using a 100 µl capillary tube. The chamber saturated for 30 minutes using the mobile phase. Acetonitrile used as single mobile phase. Then the plate was put into the chamber which containing 5 ml mobile phase until the mobile phase reaches the elution limit. Then the plate dried immediately. After that the plate is read under UV light with a wavelength of 254 nm and 366 nm using UV cabinet (CAMAG, Switzerland). 12 The sample positive if the apigenin bind appears when reading the plate under UV light. Retention factor (Rf) is expressed as the movement of separating the extract. Rf values are calculated by dividing the distance traveled by the solvent.
High performance liquid chromatography (HPLC) analysis for determination of apigenin in the extract
The HPLC analysis was used C 18 reverse-phase column (Inertsil ODS-3 5 µm, 250 x 4,6 mm, GL Science, Japan) and system (LC-20AT, Shimadzu, Kyoto, Japan), equipped with a UV-Vis detector (SPD-20A, Shimadzu, Japan) in the isocratic mode. Standard stock solution 1 mg/ml of apigenin in 80% ethanol and ethanolic extract with acid hydrolyzed used for this analysis. Sample was injected as much as 20 µl using a syringe (Agilent, Germany) then analyzed with detector wavelength 345 nm, flow rate of 0.5 ml. The mobile phase used acetonitrile-methanol with ratio 2:3. Apigenin in the extract was identified by comparing the retention time with the reference standard. Apigenin concentration was measured using the calibration curve of apigenin standard.
DPP-4 Inhibitory Activity Assay
DPP-4 activity is measured using The Glomax-Multi Detection System (Promega, USA) with an excitation wavelength of 350-360 nm and emission wavelength of 450-465 nm. Analysis of each sample was carried out in a microplate containing 96 wells. The sample was dissolved with 80% ethanol to a final concentration of 1000 ppm. Enzyme control was prepared using 80% ethanol instead of the sample. Pipetting settings can be seen in the Table 1 . After pipetting microplate incubated at 37 0 C for 30 minutes. Each test sample was analyzed in triplicate. 13 Percent inhibition was calculated using the following formula in Equation 1:
RESULT
Thin layer chromatography (TLC) profiles
Thin Layer Chromatography Profile revealed that apigenin compounds were detected in ethanolic extract with hydrolyzed acid from MA stem bark with and spot colors as shown in Figure 1 
Determination of Apigenin in the extract by HPLC analysis
The amount of apigenin on Morus alba stem bark extract was determined by the HPLC method. Ethanolic extract with hydrolyzed acid and the standard solution of apigenin were analyzed at wavelength of 345 nm. The calibration curve for apigenin standard showed on the Figure 2 . The linear equation was y = 71248x -1772,2 (R 2 = 0,99978). Test result showed that apigenin content was 0.16%. The HPLC chromatogram of Morus alba stem bark extract and apigenin standard was shown in Figures 3 and 4 .
DPP-4 inhibitory activity assay
Percent of inhibitory value is the result of DPP-4 inhibitory activity test. Table 2 shows the results of the DPP-4 inhibition test for Sitagliptin as a control inhibitor, Apigenin standard, and ethanolic with hydrolyzed acid extract. From these results it can be seen that the large inhibition by apigenin standard is 0.67 times the inhibition of sitagliptin and the large inhibition by ethanolic with hydrolyzed acid extract is 0.33 times the inhibition of sitagliptin.
DISCUSSION
The genus of Morus has long been studied and has important uses in the pharmaceutical world. Andalas (Morus macroura Miq.) Is one of the indigenous plants of Indonesia which has been designated as the mascot of West Sumatra. Morus macroura Miq contains chemical compounds that can treat various diseases such as Betulinic Acid. In addition, this plant also contains chemical compounds that can inhibit the breeding of the HIV virus, antitumor melanoma in humans and prevent inflammation. In addition, andalasin A and andalasin B are isolated as the main components of Morus macroura Miq which are potential compounds as antioxidant or tyrosinase inhibitors and can also be used as cosmetic ingredients for skin protection and bleaching or anti browning. Another member of the genus morus is Morus alba L. and Morus cathayana Hemsl. Both of these plants are very potential as economic sources and basic ingredients for making pharmaceutical preparations. The main compound found in the genus Morus is apigenin. 31 Apigenin is reported to have antioxidant effects that can be utilized in therapy for pancreatic β cell damage induced by oxidative stress. 22 In other studies, apigenin is included in the group of flavonoid compounds which have reported anti-diabetic effects through DPP-4 inhibitory mechanisms.
2,9 In this study, Apigenin level from the ethanolic extract stem bark of MA with hydrolyzed acid compared to the ethanolic extract without acid hydrolysis. From TLC, apigenin band was performed on acid hydrolyzed MA ethanolic extract, while MA ethanolic extract which was not acid hydrolyzed showed no apigenin band. This is because apigenin which is a class of flavones often found in plants in the form of glycosides. 20 To be able to detect apigenin better, action is needed to break the bonds of the glycosides. Strong acids can help break the glycoside bonds so that this study uses concentrated HCl in the extraction process. 23 The selection of optimal separation conditions depends on the specificity of analyzed sample. Despite the huge progress in separation techniques, a complex matrix cannot be injected directly into the analytical instrument. Sample pretreatment is required to remove the matrix components which could interfere with an analyte and deteriorate quality of separation or detection. Sample pretreatment is frequently used to preconcentrate the analytes of interest from the target matrices. Some types of samples such as water and other fluids are suitable for relatively simple collection and preparation. Solid samples, including fruits, plants, or vegetables, require physical homogenization and more sophisticated pretreatment. Several methods have been developed for the determination of flavonoids in plant samples. In the next step hydrolysis was aimed at breaking the bonds between β-aglycones and sugar molecules. This bond commonly known that solid tissues must be shredded and homogenized before the analysis by liquid phase separation techniques. Sample preparation method included homogenization, liquid extraction, and acid hydrolysis. 33 Glycosides are organic compounds in the plant world. Glycosides consist of two parts, namely sugar molecules (saccharides) and aglycones. Sugar groups can bind aglycone groups in various ways. The most common bond is made by oxygen atoms (O-glycons), sulfur (S-glycosides), Nitrogen (N-glycosides) or carbon (C-glycosides). Glycosides are generally solids which are soluble in water and alcohol but are slightly soluble in ether.
Glycosidic bonds are resistant to hydrolysis by alkalis but are easily broken by enzymatic reactions of dilute glycosides or mineral acids. The time needed to break the sugar bonds of flavonoids O-glycosides by acid hydrolysis is determined not only by the strength of the acid, but also by the nature of the bonding of sugar and where the sugar is attached to the nucleus of flavonoids (7-O-glycosides O-glycosides > 3-O-glycosides).
34
In this study, apigenin levels in MA ethanolic extract without acid hydrolysis was 0.04% and apigenin levels in MA ethanolic extract with acid hydrolysis was 0.16%. From these results it is known that the extraction method using acid hydrolysis attracts more apigenin compounds because the acid breaks the glycoside bond. However, the number of these compounds can be less or more with different extraction processes either from solvents or extraction methods. 11 So to get more apigenin amounts, further research is needed regarding solvents or better extraction methods.
Morus alba is one of the plants known to have anti-diabetic effects originating from traditional medicine and has been proven from various research results. Previous research found that moranoline compounds from MA root bark which have anti-diabetic activity.
14 MA branches have also been tested for their anti-diabetic effects on STZinduced mice where the results of this study indicate an increase in metabolic function in the pancreatic tissue resulting in a decrease in blood sugar level, 24 The MA fruit reported potential in the treatment of type 2 diabetes mellitus in studies using mice that had also been induced STZ, 25 and MA leaves were also reported to have anti-diabetic effects on STZ-induced mice by stimulating insulin secretion. 26 Meanwhile, the portion of the MA stem bark known to contain compounds apigenin, one of the compounds that has a potent DPP-4 inhibitory activity, 2, 8, 9 has not been studied for its anti-diabetic effect. So, this study examines the anti-diabetic effects of MA stem bark specifically through the mechanism of DPP-4 inhibitory action which is expected to complement the scientific literature on MA plants specifically related to the benefits of the treatment of diabetes mellitus. DPP-4 inhibitor activity screening test uses Cayman's Kit based on the fluorescence method. This test analyzes the free fluorogenic GlyPro-Aminomethylcoumarin (AMC) substrate released by DPP-4 by removing peptide bonds to produce fluorescence that can be analyzed using excitation wavelengths and emission wavelengths using the Glomax®-Multi Detection System (Promega, USA ). 13 From this study it was known that the inhibitory activity of DPP-4 from extracts of the stem bark of the MA was 23%. When compared with the DPP-4 inhibitor control, namely sitagliptin, the inhibitory activity of DPP-4 by MA stem bark extract was 0.33 times the inhibitory of the DPP-4 produced by sitagliptin. While the large activity of DPP-4 inhibitors of standard Apigenin is 42.13%, which is 0.67 times the inhibitory activity of sitagliptin. From these results it is known that the MA stem bark has an anti-diabetic effect through the working mechanism of the DPP-4 inhibitor which can be used as a reference for diabetes mellitus therapy. DPP-4 inhibiting agent works by increasing increatin hormone (GLP-1 and GIP) which inhibits the release of glucagon so that it can increase insulin secretion and reduce blood glucose.
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CONCLUSION
Thin Layer Chromatography Profile detected the presence of apigenin in ethanolic extract with hydrolyzed acid from MA stem bark with Rf 0.826 and the use of HPLC in the extract showed apigenin levels of 0.16% for ethanolic extract with hydrolyzed acid and 0.04% for ethanolic extract without hydrolyzed acid. It is mean hydrolyzed acid methods more effective than without hydrolyzed acid for extract apigenin.
In this study it was known that the inhibitory activity of DPP-4 from the extract of the MA stem bark was 23%. Compared to sitagliptin, the inhibitory activity of DPP-4 by extract of the MA stem bark was 0.33 times the inhibitory of DPP-4 by sitagliptin. While the large DPP-4 inhibitors activity of standard apigenin is 42.13%, which is 0.67 times the inhibitory activity of sitagliptin. From these results it is known that the MA bark has an anti-diabetic effect through the working mechanism of the DPP-4 inhibitor which can be used as a therapy for diabetes mellitus from natural ingredients.
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